| 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Van Den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ... Arthritis & Rheumatism 65 (11), 2737-2747, 2013 | 5039 | 2013 |
| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database AJ Tyndall, B Bannert, M Vonk, P Airò, F Cozzi, PE Carreira, DF Bancel, ... Annals of the rheumatic diseases 69 (10), 1809-1815, 2010 | 1482 | 2010 |
| Update of EULAR recommendations for the treatment of systemic sclerosis O Kowal-Bielecka, J Fransen, J Avouac, M Becker, A Kulak, Y Allanore, ... Annals of the rheumatic diseases 76 (8), 1327-1339, 2017 | 1089 | 2017 |
| Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients C Ferri, G Valentini, F Cozzi, M Sebastiani, C Michelassi, G La Montagna, ... Medicine 81 (2), 139-153, 2002 | 991 | 2002 |
| EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) O Kowal-Bielecka, R Landewé, J Avouac, S Chwiesko, I Miniati, L Czirjak, ... Annals of the rheumatic diseases 68 (5), 620-628, 2009 | 879 | 2009 |
| 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, A Tyndall, ... Wiley Periodicals, Inc., 2013 | 677 | 2013 |
| Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research … K Visser, W Katchamart, E Loza, JA Martinez-Lopez, C Salliot, J Trudeau, ... Annals of the rheumatic diseases 68 (7), 1086-1093, 2009 | 660 | 2009 |
| Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) GS Alarcón, G McGwin, AM Bertoli, BJ Fessler, J Calvo-Alén, HM Bastian, ... Annals of the rheumatic diseases 66 (9), 1168-1172, 2007 | 552 | 2007 |
| Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group J Avouac, J Fransen, UA Walker, V Riccieri, V Smith, C Muller, I Miniati, ... Annals of the rheumatic diseases 70 (3), 476-481, 2011 | 500 | 2011 |
| Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group S Jordan, JHW Distler, B Maurer, D Huscher, JM Van Laar, Y Allanore, ... Annals of the rheumatic diseases 74 (6), 1188-1194, 2015 | 473 | 2015 |
| European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity … G Valentini, A Della Rossa, S Bombardieri, W Bencivelli, AJ Silman, ... Annals of the rheumatic diseases 60 (6), 592-598, 2001 | 435 | 2001 |
| Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ... The Lancet Respiratory Medicine 8 (10), 963-974, 2020 | 429 | 2020 |
| Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database FMP Meier, KW Frommer, R Dinser, UA Walker, L Czirjak, CP Denton, ... Annals of the rheumatic diseases 71 (8), 1355-1360, 2012 | 400 | 2012 |
| Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis D Van der Heijde, L Klareskog, R Landewé, GAW Bruyn, A Cantagrel, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 265 | 2007 |
| Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. M Giordano, G Valentini, S Migliaresi, U Picillo, M Vatti The Journal of rheumatology 13 (5), 911-916, 1986 | 264 | 1986 |
| Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB as Novel Risk Loci for Systemic Sclerosis Y Allanore, M Saad, P Dieudé, J Avouac, JHW Distler, P Amouyel, ... PLoS genetics 7 (7), e1002091, 2011 | 253 | 2011 |
| Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter’s syndrome A Bizzarro, G Valentini, GDI MARTINO, A DaPonte, A DE BELLIS, ... The Journal of Clinical Endocrinology & Metabolism 64 (1), 32-36, 1987 | 250 | 1987 |
| The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or … M Matucci-Cerinic, Y Allanore, L Czirják, A Tyndall, U Müller-Ladner, ... Annals of the rheumatic diseases 68 (9), 1377-1380, 2009 | 214 | 2009 |
| Treatment algorithms for systemic sclerosis according to experts A Fernández‐Codina, KM Walker, JE Pope, ... Arthritis & Rheumatology 70 (11), 1820-1828, 2018 | 213 | 2018 |
| “To be or not to be,” ten years after: evidence for mixed connective tissue disease as a distinct entity S Cappelli, SB Randone, D Martinović, MM Tamas, K Pasalić, Y Allanore, ... Seminars in arthritis and rheumatism 41 (4), 589-598, 2012 | 205 | 2012 |
